PTEN and neoplasm: Upregulated expression of PTEN-Long inhibits the proliferation of breast cancer and renal cell adenocarcinoma cells and induces tumor regression in murine models of cancer, suggesting that PTEN-Long may serve as a therapeutic target in cancer (13, 18).